Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001723336 | SCV003605317 | uncertain significance | not specified | 2022-12-19 | criteria provided, single submitter | clinical testing | The c.242G>A (p.S81N) alteration is located in exon 1 (coding exon 1) of the GRPR gene. This alteration results from a G to A substitution at nucleotide position 242, causing the serine (S) at amino acid position 81 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723336 | SCV001958406 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727988 | SCV001974109 | likely benign | not provided | no assertion criteria provided | clinical testing |